Vibrio metschnikovii Pneumonia by Wallet, Frédéric et al.
LETTERS
chytrid pathogen of amphibians if a recently
emerged clone. Mol Ecol. 2003,12:
395–403.
4.  Bosch J, Martinez-Solano I, Garcia-Paris
M. Evidence of a chytrid fungus infection
involved in the decline of the common mid-
wife toad (Alytes obstetricans) in protected
areas of central Spain. Biol Conserv.
2001,97:331–7.
5. Bosch J, Martínez-Solano I. Chytrid fungus
infection related to unusual mortalities of
Salamandra salamandra and Bufo bufo in
the Peñalara Natural Park (Central Spain).
In press 2005. 
6.  Boyle DG, Boyle DB, Olsen V, Morgan
JAT, Hyatt AD. Rapid quantitative detec-
tion of chytridiomycosis (Batracho-
chytrium dendrobatidis) in amphibian sam-
ples using real-time Taqman PCR assay.
Dis Aquat Organ. 2004,60:141–8.
7.  Stagni G, Scoccianti C, Fusini R.
Segnalazione di chytridiomicosi in popo-
lazioni di Bombina pachypus (Anura,
Bombinatoridae) dell’Appennino tosco-
emiliano. Abstracts IV; Congresso della
Societas Herpetologica Italica; Napoli:
Societas Herpetologica Italica; 2002.
8.  Mutschmann F, Berger L, Zwart P,
Gaedicke C. Chytridiomycosis in amphib-
ians—first report in Europe. Berl Munch
Tierarztl. 2000,113:380–3.
9. Hanselmann R, Rodríguez A, Lampo M,
Fajardo-Ramos L, Aguirre AA, Kilpatrick
AM, et al. Presence of an emerging
pathogen of amphibians in introduced bull-
frogs Rana catesbeiana in Venezuela. Biol
Conserv. 2004,120:115–9.
10.  Daszak P, Strieby A, Cunningham AA,
Longcore JE, Brown CC, Porter D.
Experimental evidence that the bullfrog
(Rana catesbeiana) is a potential carrier of
chytridiomycosis: an emerging fungal dis-
ease of amphibians. Herpetol J.
2004,14:201–7.
11.  Piotrowski JS, Annis SL, Longcore JE.
Physiology of Batrachochytrium dendroba-
tidis, a chytrid pathogen of amphibians.
Mycologia. 2004;96:9–15.
Address for correspondence: Trenton W. J.
Garner, Institute of Zoology, Zoological
Society of London, Regent’s Park, NW1 4RY,
London, United Kingdon; fax: 44-020-7483-
2237; email: trent.garner@ioz.ac.uk
Vibrio
metschnikovii
Pneumonia
To the Editor: Vibrio metschni-
kovii is a gram-negative, oxidase-neg-
ative bacillus. This species was isolat-
ed in 1981 from blood culture of an
82-year-old diabetic woman with
cholecystitis (1). It was previously
isolated from river water, clams, oys-
ters (2), fish (3), and birds that died of
a choleralike illness (4). We report
isolation of V. metschnikovii in
bronchial aspirate from a patient with
pneumonia.
A63-year-old man was admitted to
the intensive care unit (ICU) of A.
Calmette hospital in Lille, France, for
acute respiratory failure related to
community-acquired pneumonia. The
patient had a history of chronic
obstructive pulmonary disease with a
forced expiratory volume of 820 mL
in 1 s (32% of predictive value); he
was treated with oral salmeterol,
terbutaline, and prednisolone (40
mg/day). He was HIV negative. On
ICU admission, he had the following
values: respiratory rate 30/min, tem-
perature 39°C, pulse rate 140/min,
blood pressure 140/90 mm Hg,
Glasgow coma score 15, leukocyte
count 13.7 × 109/L, hemoglobin level
10.2 g/dL, procalcitonin level 22
ng/mL, and C-reactive protein level
73 mg/L. A chest radiograph showed
diffuse bilateral infiltrates. Analysis
of arterial blood gases with 6Lof oxy-
gen/min showed respiratory acidosis:
pH 7.30, pCO2 59 mm Hg, pO2 78
mm Hg, HCO3 23 mmol/L, O2 satura-
tion 94%. Other laboratory test results
were normal. After noninvasive venti-
lation failed, the patient was immedi-
ately intubated and mechanically
ventilated.
Blood cultures and bronchial aspi-
rate samples were obtained before ini-
tiating treatment with antimicrobial
drugs. The patient was treated with
amoxicillin/clavulanic acid and
ciprofloxacin. Blood cultures showed
negative results. Microscopic exami-
nation of the bronchial aspirate
showed no squamous epithelial cells,
a few gram-negative bacilli, leuko-
cytes, and many ciliated bronchial
cells. The presence of ciliated cells
was the best indicator that secretions
originated from the lower respiratory
tract. A urinary antigenic test result
for  Legionella spp. was negative.
Quantitative culture of the bronchial
aspirate on bromocresol purple agar,
blood agar (grown in an atmosphere
of 5% CO2), and chocolate agar plates
yielded  V. metschnikovii (107
CFU/mL) and nonhemolytic strepto-
cocci (105 CFU/mL) as the oropha-
ryngeal flora. These streptococci
(gram-positive, catalase-negative)
were not considered to be the patho-
genic agent.
The strain of V. metschnikovii iso-
lated was a gram-negative, curved
rod. This facultative aeroanaerobic
bacillus formed opaque colonies
(diameter 3 mm) on blood agar in 24
h and showed complete hemolysis. It
was catalase positive, oxidase nega-
tive, and did not reduce nitrate to
nitrite. This strain was identified as V.
metschnikovii with an ID GBN Vitek
2 card (bioMérieux, Marcy l’Etoile,
France) (acceptable T identification
index 0.22). Confirmation was done
with a Microseq 500 16S ribosomal
DNA bacterial kit (PE Applied
Biosystems, Foster City, CA, USA).
A 475-bp fragment was sequenced in
an automated sequencer (360 ABI
Prism, PE Applied Biosystems). The
fragment was compared with National
Center for Biotechnology Information
(Bethesda, MD, USA) GenBank
entries and showed 99% homology
with  V. metschnikovii (GenBank
accession no. X74712.1). In vitro sus-
ceptibility testing with the AST-N032
Vitek 2 card (bioMérieux) showed
that the organism was resistant to
ampicillin, ticarcillin, piperacillin,
and aminoglycosides.
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The patient was successfully extu-
bated. He was transferred to a pneu-
mology ward on day 9 and discharged
on day 15. Antimicrobial treatment
was stopped on day 10.
Most nonhuman strains of V.
metschnikovii  are usually found in
aquatic habitats (e.g., lakes and
marine waters). Human clinical infec-
tions with this bacterium are rare;
however, cases of epidemic diarrhea
caused by V. metschnikovii have been
reported (5,6). Contamination by
water or fish was not always demon-
strated in these cases, but an orofecal
source is possible. In coproculture,
this microorganism is probably not
diagnosed: it was initially identified
as normal aerobic flora because it was
oxidase negative.
The first case of septicemia with V.
metschnikovii was reported in 1981 in
a patient with peritonitis and an
inflamed gallbladder (1). Three other
patients with similar septicemia, all
>70 years of age, were described
(7,8); 2 had polymicrobial results in
blood cultures. V. metschnikovii was
also found in a mucocutaneous site
(wound infection) after saphenectomy
in swab samples of the wound site (9). 
The patient in our study denied
contact with lake or sea water, and he
had not eaten any seafood. He was a
retired carpenter without contact with
domestic or wild animals and did not
recall an episode of diarrhea before
his hospitalization. The source of con-
tamination that caused his acute respi-
ratory failure was not identified. 
Miyake et al. showed that V.
metschnikovii  produces a cytolysin
with hemolytic properties (10). This
finding might explain the invasive
process of this bacterium, which
resulted in pulmonary lesions in a
patient with respiratory deficiency.
As far as we know, this is the first
case of pneumonia caused by V.
metschnikovii.
Frédéric Wallet,* Mickaël Tachon,*
Saad Nseir,* René J. Courcol,* 
and Micheline Roussel-Delvallez*
*Lille University Medical Center, Lille,
France
References
1.  Jean-Jacques W, Rajashekaraiah KR,
Farmer JJ, Hickman FW, Morris JG, Kallick
CA. Vibrio metschnikovii bacteremia in a
patient with cholecystitis. J Clin Microbiol.
1981;14:711–2.
2.  Lee JV, Donovan TJ, Furniss AL.
Characterization, taxonomy, and emended
description of Vibrio metschnikovii. Int J
Syst Bacteriol. 1978;28:99–111.
3. Hansen W, Pohl P, Seynave D, Bughin J,
Yourassowski E. Isolements de Vibrio
metschnikovii en Belgique. Ann Med Vet.
1989;133:343–6.
4.  Farmer JJ III, Hickman-Brenner FW,
Fanning GR, Gordon CM, Brenner DJ.
Characterization of Vibrio metschnikovii
and  Vibrio gazogenes by DNA-DNA
hybridization and phenotype. J Clin
Microbiol. 1988;26:1993–2000.
5. Dalsgaard A, Alarcon A, Lanata CF, Jensen
T, Hansen HJ, Delgado F, et al. Clinical
manifestations and molecular epidemiology
of five cases of diarrhoea in children asso-
ciated with Vibrio metschnikovii in
Arequipa, Peru. J Med Microbiol.
1996;45:494–500.
6. Magalhaes V, Branco A, de Andrade Lima
R, Magalhaes M. Vibrio metschnikovii
among diarrheal patients during cholera
epidemic in Recife, Brazil. Rev Inst Med
Trop Sao Paulo. 1996;38:1–3.
7.  Hansen W, Freney J, Benyagoub H,
Letouzey MN, Gigi J, Wauters G. Severe
human infections caused by Vibrio
metschnikovii. J Clin Microbiol.
1993;31:2529–30.
8.  Hardardottir H, Vikenes K, Digranes A,
Lassen J, Halstensen A. Mixed bacteremia
with Vibrio metschnikovii in a 83-year-old
female patient. Scand J Infect Dis.
1994;26:493–4.
9. Linde HJ, Kobuch R, Jayasinghe S, Reischl
U, Lehn N, Kaulfuss S, et al. Vibrio
metschnikovii, a rare cause of wound infec-
tion. J Clin Microbiol. 2004;42:4909–11.
10. Miyake M, Honda T, Miwatani T.
Purification and characterization of Vibrio
metschnikovii cytolysin. Infect Immun.
1988;56:954–60.
Address for correspondence: Frédéric Wallet,
Laboratoire de Bactériologie-Hygiène,
Boulevard du Pr Leclercq, 59037 Lille Cedex,
France; fax: 33-3-20-44-48-95; email:
fwallet@chru-lille.fr
Lassa Fever,
Nigeria, 2003 
and 2004
To the Editor: Suspected out-
breaks of Lassa fever have been
reported in the northern part of Edo,
Nigeria, including Ekpoma, Igarra,
and Ibilo, in 2001 and between
November 2003 and March 2004
(1,2). To confirm Lassa fever activity
in this area, serum samples were col-
lected at the Specialist Teaching
Hospital in Irrua (ISTH) from
September 2003 to January 2004.
Approximately 16,000 patients are
seen each year at ISTH, and ≈80% of
them have febrile illness. Serum spec-
imens were taken from patients with
febrile illness (n = 31), healthy con-
tact persons (n = 17), and healthy hos-
pital staff (n = 12). The samples were
analyzed by Lassa virus–specific
reverse-transcriptase polymerase
chain reaction (RT-PCR) at the
University of Lagos. Aliquots of spec-
imens were sent to the Bernhard-
Nocht Institute (BNI in Hamburg,
Germany) for confirmatory PCR
analysis, serologic testing, and virus
isolation. The PCR used at both facil-
ities was based on primers 80F2 and
36E2 that targeted the glycoprotein
precursor (GPC) gene (3), although
the protocols were slightly different.
At BNI, virus RNA was purified by
QIAamp viral RNA kit (Qiagen,
Hilden, Germany), and RT-PCR was
performed with Superscript II
RT/Platinum Taq polymerase 1-step
reagents (Invitrogen, Karlsruhe,
Germany). This PCR assay has a 95%
detection limit of 2,500 copies/mL
(4). At the University of Lagos, virus
RNA purification and RT-PCR were
performed with diatomaceous silica
and Brilliant single-step RT-PCR kit
(Stratagene, Heidelberg, Germany),
respectively. Serologic testing for
Lassa virus–specific immunoglobulin
G (IgG) and IgM was performed by
indirect immunofluorescence assay
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